ATC code C03
ATC code C03 Diuretics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup C03 is part of the anatomical group C Cardiovascular system.[4]
| ATC codes |
|---|
| C Cardiovascular system |
| C01 Cardiac therapy |
| C02 Antihypertensives |
| C03 Diuretics |
| C04 Peripheral vasodilators |
| C05 Vasoprotectives |
| C07 Beta blocking agents |
| C08 Calcium channel blockers |
| C09 Agents acting on the renin–angiotensin system |
| C10 Lipid modifying agents |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC03.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C03A Low-ceiling diuretics, thiazides
C03AA Thiazides, plain
- C03AA01 Bendroflumethiazide
- C03AA02 Hydroflumethiazide
- C03AA03 Hydrochlorothiazide
- C03AA04 Chlorothiazide
- C03AA05 Polythiazide
- C03AA06 Trichlormethiazide
- C03AA07 Cyclopenthiazide
- C03AA08 Methyclothiazide
- C03AA09 Cyclothiazide
- C03AA13 Mebutizide
- QC03AA56 Trichlormethiazide, combinations
C03AB Thiazides and potassium in combination
- C03AB01 Bendroflumethiazide and potassium
- C03AB02 Hydroflumethiazide and potassium
- C03AB03 Hydrochlorothiazide and potassium
- C03AB04 Chlorothiazide and potassium
- C03AB05 Polythiazide and potassium
- C03AB06 Trichlormethiazide and potassium
- C03AB07 Cyclopenthiazide and potassium
- C03AB08 Methyclothiazide and potassium
- C03AB09 Cyclothiazide and potassium
C03AH Thiazides, combinations with psycholeptics and/or analgesics
- C03AH01 Chlorothiazide, combinations
- C03AH02 Hydroflumethiazide, combinations
C03AX Thiazides, combinations with other drugs
- C03AX01 Hydrochlorothiazide, combinations
C03B Low-ceiling diuretics, excluding thiazides
C03BA Sulfonamides, plain
- C03BA02 Quinethazone
- C03BA03 Clopamide
- C03BA04 Chlortalidone
- C03BA05 Mefruside
- C03BA07 Clofenamide
- C03BA08 Metolazone
- C03BA09 Meticrane
- C03BA10 Xipamide
- C03BA11 Indapamide
- C03BA12 Clorexolone
- C03BA13 Fenquizone
- C03BA82 Clorexolone, combinations with psycholeptics
C03BB Sulfonamides and potassium in combination
- C03BB02 Quinethazone and potassium
- C03BB03 Clopamide and potassium
- C03BB04 Chlortalidone and potassium
- C03BB05 Mefruside and potassium
- C03BB07 Clofenamide and potassium
C03BC Mercurial diuretics
- C03BC01 Mersalyl
C03BD Xanthine derivatives
- C03BD01 Theobromine
C03BX Other low-ceiling diuretics
- C03BX03 Cicletanine
C03C High-ceiling diuretics
C03CA Sulfonamides, plain
- C03CA01 Furosemide
- C03CA02 Bumetanide
- C03CA03 Piretanide
- C03CA04 Torasemide
C03CB Sulfonamides and potassium in combination
- C03CB01 Furosemide and potassium
- C03CB02 Bumetanide and potassium
C03CC Aryloxyacetic acid derivatives
- C03CC01 Etacrynic acid
- C03CC02 Tienilic acid
C03CD Pyrazolone derivatives
- C03CD01 Muzolimine
C03CX Other high-ceiling diuretics
- C03CX01 Etozolin
C03D Aldosterone antagonists and other potassium-sparing agents
C03DA Aldosterone antagonists
- C03DA01 Spironolactone
- C03DA02 Potassium canrenoate
- C03DA03 Canrenone
- C03DA04 Eplerenone
- C03DA05 Finerenone
C03DB Other potassium-sparing agents
- C03DB01 Amiloride
- C03DB02 Triamterene
C03E Diuretics and potassium-sparing agents in combination
C03EA Low-ceiling diuretics and potassium-sparing agents
- C03EA01 Hydrochlorothiazide and potassium-sparing agents
- C03EA02 Trichlormethiazide and potassium-sparing agents
- C03EA03 Epitizide and potassium-sparing agents
- C03EA04 Altizide and potassium-sparing agents
- C03EA05 Mebutizide and potassium-sparing agents
- C03EA06 Chlortalidone and potassium-sparing agents
- C03EA07 Cyclopenthiazide and potassium-sparing agents
- C03EA12 Metolazone and potassium-sparing agents
- C03EA13 Bendroflumethiazide and potassium-sparing agents
- C03EA14 Butizide and potassium-sparing agents
C03EB High-ceiling diuretics and potassium-sparing agents
- C03EB01 Furosemide and potassium-sparing agents
- C03EB02 Bumetanide and potassium-sparing agents
C03X Other diuretics
C03XA Vasopressin antagonists
- C03XA01 Tolvaptan
- C03XA02 Conivaptan
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code C03". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QC03". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.